These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 24472456)
1. [Towards a bivalent prophylactic vaccine against hepatitis B and C viruses?]. Beaumont E; Roingeard P Med Sci (Paris); 2014 Jan; 30(1):33-5. PubMed ID: 24472456 [No Abstract] [Full Text] [Related]
2. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine. Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224 [TBL] [Abstract][Full Text] [Related]
3. Vaccination against hepatitis B and C: towards therapeutic application. Inchauspe G; Bach G; Martin P; Bonnefoy JY Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251 [No Abstract] [Full Text] [Related]
4. Strategies and prospects for vaccination against the hepatitis C viruses. Houghton M Curr Top Microbiol Immunol; 2000; 242():327-39. PubMed ID: 10592667 [No Abstract] [Full Text] [Related]
5. [Approaches to developing an optimal vaccine against hepatitis B viruses]. Gerlich WH; Heermann KH; Thomssen R Immun Infekt; 1988 Oct; 16(5):167-74. PubMed ID: 3061927 [TBL] [Abstract][Full Text] [Related]
6. Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses. Houghton M Immunol Rev; 2011 Jan; 239(1):99-108. PubMed ID: 21198667 [TBL] [Abstract][Full Text] [Related]
7. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178 [No Abstract] [Full Text] [Related]
8. [Chronic viral hepatitis--hope of solving a worldwide problem]. Marbet UA Schweiz Rundsch Med Prax; 1990 Nov; 79(47):1463-8. PubMed ID: 1709512 [TBL] [Abstract][Full Text] [Related]
11. [Various forms of hepatitis and their prevention]. Reesink HW Ned Tijdschr Geneeskd; 1987 May; 131(19):812-4. PubMed ID: 3108679 [No Abstract] [Full Text] [Related]
12. [Immunoprophylaxis of viral hepatitis]. Biesiada G; Mach T Przegl Lek; 2003; 60(9):598-601. PubMed ID: 15065341 [TBL] [Abstract][Full Text] [Related]
13. What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States? Buckley GJ; Strom BL Ann Intern Med; 2016 Aug; 165(4):284-5. PubMed ID: 27064885 [No Abstract] [Full Text] [Related]
14. Statement on hepatitis vaccines for travellers. An Advisory Committee Statement (ACS). Committee to Advise on Tropical Medicine and Travel (CATMAT) Can Commun Dis Rep; 2008 Jul; 34(ACS-2):1-24. PubMed ID: 18802989 [No Abstract] [Full Text] [Related]
15. Viral hepatitis: update on prevention. Alter MJ Henry Ford Hosp Med J; 1984; 32(2):101-6. PubMed ID: 6439691 [No Abstract] [Full Text] [Related]
16. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection. Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986 [TBL] [Abstract][Full Text] [Related]
17. Score: hepatitis viruses 5, vaccines 1. Researchers believe sixth virus exists. Russell B Am Nurse; 1992 Sep; 24(8):1, 11. PubMed ID: 1387770 [No Abstract] [Full Text] [Related]
18. [Current status and strategy of the research on hepatitis C vaccine]. Nie Q; Li M Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):47-9. PubMed ID: 10322709 [No Abstract] [Full Text] [Related]
19. [Perspectives of developing a vaccine against hepatitis C virus]. Skarpetowski AC; MadaliĆski K Pediatr Pol; 1996 Apr; 71(4):295-300. PubMed ID: 8975215 [TBL] [Abstract][Full Text] [Related]